InvestorsHub Logo
Followers 15
Posts 428
Boards Moderated 0
Alias Born 10/03/2013

Re: coreycroo post# 86449

Tuesday, 04/07/2015 8:28:11 AM

Tuesday, April 07, 2015 8:28:11 AM

Post# of 91007
Hi Corey,

Welcome back, you’ve not missed much…

There’s been no news at all, other than the stuff you may already know about (the flask with Hielscher Ultrasonics and the Invigorcell IND for Diabetes).

There’s been no update on the YA Global financing agreement or other investors through Dawson James and Dinosaur.

We’ve heard nothing about Andrews either (other than a comment a couple of months ago saying that there might be a report due in March).

However, a number of people, myself included think that there’s a lot going on behind the scenes and that the funding is probably in place once Andrews/FDA/EU patent issues are resolved and that is precisely the reason we’ve heard nothing. The ultrasound flask with Hielscher could be an improvement to the process or FDA input to enhance safety but that’s just speculation.

A few people or organisations) out there look to be buying up big blocks of shares so there’s a number of us think that there’s some accumulation going on –why, we don’t know but it’s not beyond the realms of possibility that these parties know what’s happening and are buying now while the price is at rock bottom.

The 2014 10K is now overdue but no-one’s surprised as it follows the pattern of previous filings and the NT 10K stated that there were no significant changes in results of operations from last year. However, that doesn’t mean that there won’t be anything to report as there could finally be some news to report and this might be the time to release (or not)…

Understandably there are a lot of people starting to get a little p***ed at the situation but there’s nothing we can do.

Can’t really say more than that as there’s not much else to say…

Thoughts…

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.